Surgery
Volume 141, Issue 6 , Pages 736-747 , June 2007

Preoperative mapping of lymphatic drainage from the tumor using ferumoxide-enhanced magnetic resonance imaging in clinical submucosal thoracic squamous cell esophageal cancer

  • Satoru Motoyama, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Japan
    • Corresponding Author InformationReprint requests: Satoru Motoyama, Dept. of Surgery, Akita University School of Medicine, Akita City, 010-8543, Japan.
    • ,
  • Koichi Ishiyama, MD

      Affiliations

    • Department of Radiology, Akita University School of Medicine, Japan
    • ,
  • Kiyotomi Maruyama, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Japan
    • ,
  • Manabu Okuyama, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Japan
    • ,
  • Yusuke Sato, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Japan
    • ,
  • Kaori Hayashi, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Japan
    • ,
  • Hiroshi Nanjo, MD

      Affiliations

    • Department of Pathology, Akita University School of Medicine, Japan
    • ,
  • Hajime Saito, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Japan
    • ,
  • Yoshihiro Minamiya, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Japan
    • ,
  • Jun-ichi Ogawa, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Japan

,Accepted 7 January 2007.

References 

  1. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–372
  2. Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, Makino T, et al. Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer. 1999;80:1281–1288
  3. Kawahara K, Maekawa T, Okabayashi K, Shiraishi T, Yoshinaga Y, Yoneda S, et al. The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol. 1998;67:160–163
  4. Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, et al. Mortality and morbidity rates, postoperative course, quality of life and prognosis after radical lymphadenectomy for esophageal cancer. Ann Surg. 1995;222:654–662
  5. Motoyama S, Kitamura M, Saito R, Maruyama K, Okuyama M, Ogawa J. Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck. World J Surg. 2006;30:191–198
  6. Sato T, Sakamoto K. Illustration and photographs of surgical esophageal anatomy specially prepared for lymph node dissection. In: Color atlas of surgical anatomy for esophageal cancer. Berlin, Heidelberg, New York: Springer; 1992;p. 25–90
  7. Murakami G, Abe M, Abe T. Last-intercalated node and direct lymphatic drainage into the thoracic duct from the thoracoabdominal viscera. Jpn J Thorac Cardiovasc Surg. 2002;50:93–103
  8. Matsubara T, Ueda M, Kaisaki S, Kuroda J, Uchida C, Kokudo N, et al. Location of initial lymph node metastasis from carcinoma of the thoracic esophagus. Cancer. 2000;89:1869–1873
  9. Matsubara T, Ueda M, Abe T, Akimori T, Kokudo N, Takahashi T. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus. Br J Surg. 1999;86:669–673
  10. Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Coll Surg. 2006;202:604–611
  11. Dooms GC, Hricak H. Radiologic imaging modalities, including magnetic resonance, for evaluating lymph nodes. West J Med. 1986;144:49–57
  12. Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg. 2004;239:483–490
  13. Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus. 2000;13:125–129
  14. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  15. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–1867
  16. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol. 2000;7:120–124
  17. Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Ozawa S, et al. Intraoperative lymphatic mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am. 2002;11:293–304
  18. Hayashi H, Ochiai T, Mori M, Karube T, Suzuki T, Gunji Y, et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg. 2003;196:68–74
  19. Arigami T, Natsugoe S, Uenosono Y, Mataki Y, Ehi K, Higashi H, et al. Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg. 2006;243:341–347
  20. Nakagawa T, Minamiya Y, Katayose Y, Saito H, Taguchi K, Imano H, et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:563–567
  21. Minamiya Y, Ito M, Katayose Y, Saito H, Imai K, Sato Y, et al. Intraoperative sentinel lymph node mapping using a new sterilizable magnetometer in patients with nonsmall cell lung cancer. Ann Thorac Surg. 2006;81:327–330
  22. Imano H, Motoyama S, Saito R, Minamiya Y, Katayose Y, Okuyama M, et al. Superior mediastinal and neck lymphatic mapping in mid- and lower-thoracic esophageal cancer as defined by ferumoxides-enhanced magnetic resonance imaging. Jpn J Thorac Cardiovasc Surg. 2004;52:445–450
  23. Japan Society for Esophageal Diseases. Guidelines for clinical and pathologic studies on carcinoma of the esophagus. 9th edition. Preface, general principles, part I. Esophagus. 2004;1:61–88
  24. Ishiyama K, Motoyama S, Tomura N, Sashi R, Imano H, Ogawa J, et al. Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer. J Comput Assist Tomogr. 2006;30:270–275
  25. Saini S, Stark DD, Hahn PF, Wittenberg J, Brady TJ, Ferrucci JT. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology. 1987;162:211–216
  26. Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425–433
  27. Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 2003;238:339–347

PII: S0039-6060(07)00125-0

doi: 10.1016/j.surg.2007.01.032

Surgery
Volume 141, Issue 6 , Pages 736-747 , June 2007

Article Tools

* Image Usage & Resolution